Vericel (VCEL) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Vericel (VCEL) Tops Q4 EPS by 7c, Revenues Beat; Offers FY19 Revenue Outlook

Vericel Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Full-Year 2019 Financial Guidance

February 26, 2019 7:30 AM EST

Record Quarterly Product Revenues of $31.3 Million Represent a 41% Increase Over Fourth Quarter 2017

Full-Year 2018 Product Revenues of $90.9 Million

Conference Call Today at 8:30am Eastern Time

CAMBRIDGE, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the fourth quarter and year ended December 31, 2018 and provided full-year 2019 financial guidance.

Fourth Quarter 2018 Financial Highlights

... More